Quell

AstraZeneca Enters $2 Billion Deal with Quell for Treg Cell Therapy

AstraZeneca Enters $2 Billion Deal with Quell for Treg Cell Therapy

SG Tylor

British start-up Quell Therapeutics has secured a collaboration with AstraZeneca focused on cell therapies for autoimmune diseases, with an upfront ...